Clinical Trials Logo

Clinical Trial Summary

We are interested in investigating the functional brain abnormalities of height phobia. Subjects will be have a functional MRI scan before and after a course of treatment with behavioral therapy.


Clinical Trial Description

The purpose of this study is to investigate the effects of in vivo exposure therapy on the functional brain activity of subjects with height phobia using a fear provocation paradigm. We expect differential activation of the fear circuitry in height phobics compared to non-phobic controls, and that successful behavioral therapy will normalize the heightened fear response in height phobia. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00302978
Study type Interventional
Source New York State Psychiatric Institute
Contact
Status Completed
Phase N/A
Start date March 2006
Completion date June 2006

See also
  Status Clinical Trial Phase
Completed NCT04003753 - Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of Heights N/A
Completed NCT03907345 - Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure N/A
Enrolling by invitation NCT05824884 - Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights N/A
Completed NCT04737915 - Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights N/A
Completed NCT04975854 - Virtual Reality Exposure Therapy for Acrophobia N/A
Completed NCT02361203 - Exercise and Virtual Reality Exposure Therapy for Acrophobia N/A
Suspended NCT03917433 - Augmenting Virtual Reality Exposure Therapy for Acrophobia N/A